RRPV Solicitation Summary: Rapid Antigen Production for Immunoassay Diagnostics (RAPID)

The Rapid Response Partnership Vehicle (RRPV) Consortium, on behalf of the Biomedical Advanced Research and Development Authority (BARDA), is seeking proposals for the Rapid Antigen Production for Immunoassay Diagnostics (RAPID) project. The goal of this project is to support advanced research and development of rapid antibody and other protein-based molecular recognition reagent generation platforms to enable timely production of immunoassay-ready reagents for diagnostic use. The objective is to establish flexible, end-to-end systems capable of generating high-performance binders against known and emerging biological threats. • The project aims to compress development timelines from pathogen sequence to assay-ready reagents, ideally within weeks. • A Proposer’s Conference and Teaming Connect will be held virtually on April 27, 2026. • The full RPP and registration information can be accessed through the RRPV website.